Pharmaceuticals
10 Pfizer marketing leaders
These ten current and former Pfizer marketing leaders have held director-level and higher marketing roles at Pfizer, including a senior vice president and global marketing lead and vice presidents in vaccines, oncology and neuroscience marketing. A reader can learn how Pfizer plans global and US marketing for vaccines, oncology, rare disease and inflammation brands, including launches.
Professionals to explore
01—10Amy Buffetti Kreisberg
LinkedInExperience: Global Marketing Lead- Adult Vaccines Portfolio · Pfizer
Global Marketing Lead- Adult Vaccines Portfolio at Pfizer since 2024, following Senior Director - Global Marketing Team Lead - Vaccines (2023–2024) and Senior Director - Global Marketing Team Lead - Internal Medicine (2021–2023) at Pfizer. Amy Buffetti Kreisberg also held Director - Global Marketing and Commercial Development - Internal Medicine (2018–2021) at Pfizer.
Ana Maria Luque
LinkedInExperience: Vice President of Global Marketing Vaccines Franchise · Pfizer
Vice President of Global Marketing Vaccines Franchise at Pfizer since 2019, following Regional Vice President Marketing Vaccines at International Develop Markets, Europe-Asia (2016–2019) at Pfizer. Ana Maria Luque was also Country Manager Venezuela (2013–2016) and Commercial VP of Established Products Emerging Markets Business Unit (2009–2013) at Pfizer.
Brigitte Ripert
LinkedInExperience: Global Marketing Director - Rare Diseases - Growth Hormone Franchise · Pfizer
Global Marketing Director - Rare Diseases - Growth Hormone Franchise at Pfizer since 2023, where the profile mentions driving uptake of the new growth hormone product Ngenla. Brigitte Ripert was Global Marketing Director - Oncology - Breast Cancer - Ibrance (2019–2023) and Brand Director Europe - Oncology - Renal Cell Carcinoma (Inlyta prelaunch launch) (2011–2014) at Pfizer.
Carlos Moscol
LinkedInExperience: Vice President, Global Marketing Lead, Neuroscience and Pain · Pfizer
Former Vice President, Global Marketing Lead, Neuroscience and Pain at Pfizer (2016–2018), where the profile says Carlos Moscol led the Global Marketing team for a portfolio of neuroscience and pain phase 3 and in-line medicines, including tanezumab. Carlos Moscol was Vice President, Regional Sales Leader, USA Midwest at Pfizer (2018–2020) and has been an Independent Business Advisor and Consultant since 2021.
Erling T. Donnelly
LinkedInExperience: Senior Vice President, Global Marketing Lead · Pfizer
Senior Vice President, Global Marketing Lead at Pfizer since February 2026, following Vice President, US Breast Cancer Franchise & Portfolio Marketing Lead at Pfizer (2021–2026). Erling T. Donnelly also held Vice President, Hematology Franchise Lead (2024–2025) and Oncology Lead, United Kingdom (2019–2021) at Pfizer; the profile says Erling led the Development team for IBRANCE and VIZIMPRO.
Gloria Choi
LinkedInExperience: Oncology, VP, US PADCEV Brand Lead · Pfizer
Oncology, VP, US PADCEV Brand Lead at Pfizer since April 2026; the profile says the role covers P&L management and leading a team of 7 FTEs to develop and execute brand strategies across customer sets. Gloria Choi was Oncology, US Vepdegestrant Brand Lead (2024–2025) and Oncology, US IBRANCE Brand Lead (2022–2025) at Pfizer.
Sandra Bunke-Koelblin
LinkedInExperience: Marketing Director Oncology · Pfizer
Marketing Director Oncology at Pfizer since December 2025; the profile says Sandra Bunke-Koelblin leads teams across multiple indications and products. Sandra Bunke-Koelblin was Marketing Lead Neuroscience (2019–2024) and Head of Transformation & Innovation Excellence (2024–2025) at Johnson & Johnson Innovative Medicine.
Shera D. Gruen
LinkedInExperience: Vice President, Marketing, US and Global Vaccines · Pfizer
Former Vice President, Marketing, US and Global Vaccines at Pfizer (2022–2024), following Vice President Marketing Lead, U.S. Pediatric & Adolescent Vaccines (2021–2022). The profile describes a specialty in product launches, market access, commercialization and marketing strategies; Shera D. Gruen has been Senior Vice President at Lumanity since 2025.
Sonali Jasmin
LinkedInExperience: Senior Director, Global Marketing Excellence · Pfizer
Senior Director, Global Marketing Excellence at Pfizer since 2023; the profile says the role leads marketing insights and strategy excellence for the Chief Marketing Office. Sonali Jasmin was Director, Global Marketing Inflammation & Immunology (2018–2021) and Omnichannel Marketing Lead - Agile Team (2021–2022) at Pfizer.
Sophia Patel
LinkedInExperience: Global Marketing Director - Launch Lead, VELSIPITY · Pfizer
Global Marketing Director - HCP Strategy, Mevrometostat at Pfizer since February 2026, a prostate cancer role according to the profile. Sophia Patel was Global Marketing Director - Launch Lead, VELSIPITY (2024–2026), Global Marketing Director - HCP and Patient Customer Experience, VELSIPITY (2022–2024) and Senior Marketing Manager, US ELIQUIS HCP Indication Lead (2018–2020) at Pfizer.
Choose the right perspective
Match the person's therapeutic area and market to your question, since vaccine, oncology and rare disease brands are marketed to different customers, and global and US roles cover different work. Check each person's dates before asking about recent practice, because two of them have left Pfizer.
Questions to take into the conversation
- 01How do global and country marketing teams split responsibility for a brand's strategy and execution?
- 02What does a strong launch plan for a new medicine or vaccine look like in the year before approval?
- 03How do you measure whether marketing to physicians and to patients is working for an in-line brand?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal